Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone binding

CTCFL ZZZ3 IPO9 SETD5 TSPYL2 SSRP1 APLF

2.18e-05265647GO:0042393
GeneOntologyBiologicalProcessprotein-DNA complex organization

NRDE2 SAMD1 CTCFL ZZZ3 SETD5 PPM1D TSPYL2 TAF2 SSRP1 YTHDC1 PHF10 APLF

5.84e-059996512GO:0071824
GeneOntologyBiologicalProcesschromatin remodeling

NRDE2 SAMD1 CTCFL SETD5 PPM1D TSPYL2 SSRP1 YTHDC1 PHF10 APLF

1.01e-047416510GO:0006338
GeneOntologyBiologicalProcesschromatin organization

NRDE2 SAMD1 CTCFL ZZZ3 SETD5 PPM1D TSPYL2 SSRP1 YTHDC1 PHF10 APLF

1.02e-048966511GO:0006325
DomainSSX

SSX2 SSX3 SSX5

7.99e-076653IPR028804
DomainSSXRD

SSX2 SSX3 SSX5

2.23e-068653PF09514
DomainSSXRD_motif

SSX2 SSX3 SSX5

2.23e-068653IPR019041
DomainKRAB_RELATED

SSX2 SSX3 SSX5

6.51e-0611653PS50806
DomainKrueppel-associated_box-rel

SSX2 SSX3 SSX5

1.12e-0513653IPR003655
DomainProtein_Kinase_C_mu-related

PRKD3 PRKD2

3.57e-053652IPR015727
DomainPP2C

PPM1D PHLPP2

1.96e-0319652PF00481
DomainPP2Cc

PPM1D PHLPP2

2.18e-0320652SM00332
DomainPPM-type_phosphatase_dom

PPM1D PHLPP2

2.18e-0320652IPR001932
Domain-

PPM1D PHLPP2

2.18e-03206523.60.40.10
DomainPPM_2

PPM1D PHLPP2

2.18e-0320652PS51746
DomainDAG/PE-bd

PRKD3 PRKD2

2.40e-0321652IPR020454
DomainARM-type_fold

IPO9 APC TTI1 FRYL TAF2

6.49e-03339655IPR016024
Domain-

IPO9 APC TTI1 FRYL

7.47e-032226541.25.10.10
DomainSer/Thr_kinase_AS

PRKD3 PRKD2 BMP2K SIK2 RPS6KC1

8.03e-03357655IPR008271
DomainAnk

ANK1 ANKRD26 POTEJ ANKHD1

8.19e-03228654PF00023
DomainS_TKc

PRKD3 PRKD2 BMP2K SIK2 RPS6KC1

8.21e-03359655SM00220
DomainPROTEIN_KINASE_ST

PRKD3 PRKD2 BMP2K SIK2 RPS6KC1

8.50e-03362655PS00108
Pubmed

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

SSX2 SSX3 SSX5

2.61e-08466310749136
Pubmed

The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP.

SSX2 SSX3 SSX5

3.63e-07866312007189
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

NRDE2 SAMD1 STRN BMP2K SETD5 RBM33 APC SCAF11 TAF2 SSRP1 ANKHD1 YTHDC1 PREX1 THAP12

6.68e-071497661431527615
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

NRDE2 BMP2K RBM33 PRRC2C APC ANKRD26 TAF2 ANKHD1 MGA PHF10

1.06e-06724661036232890
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

STRN ZZZ3 RBM33 PPM1D PRRC2C APC ANKRD26 POTEJ HSF2

1.67e-0658866938580884
Pubmed

Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.

PRKD3 PRKD2

3.55e-06266224840177
Pubmed

Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.

SSX2 SSX5

3.55e-06266216546222
Pubmed

Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.

PRKD3 PRKD2

3.55e-06266230841931
Pubmed

Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.

PRKD3 PRKD2

3.55e-06266225802335
Pubmed

Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.

PRKD3 PRKD2

3.55e-06266223393329
Pubmed

Protein kinase D3 conditional knockout impairs osteoclast formation and increases trabecular bone volume in male mice.

PRKD3 PRKD2

3.55e-06266237044359
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PRKD2 SAMD1 ZZZ3 SETD5 TSPYL2 TAF2 REV3L SSRP1 ANKHD1 MGA PHF10

7.55e-061116661131753913
Pubmed

The SSX gene family: characterization of 9 complete genes.

SSX2 SSX3 SSX5

8.47e-062166312216073
Pubmed

Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.

PRKD3 PRKD2

1.06e-05366226253275
Pubmed

Expression of the protein kinase D (PKD) family during mouse embryogenesis.

PRKD3 PRKD2

1.06e-05366216377259
Pubmed

A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY.

PRKD3 PRKD2

1.06e-05366227662904
Pubmed

Inhibition of protein kinase D by CID755673 promotes maintenance of the pluripotency of embryonic stem cells.

PRKD3 PRKD2

1.06e-05366232747433
Pubmed

Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.

PRKD3 PRKD2

1.06e-05366226426580
Pubmed

SSX2-4 expression in early-stage non-small cell lung cancer.

SSX2 SSX3

1.06e-05366224645645
Pubmed

Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development.

APC IL17RA

1.06e-05366238947320
Pubmed

Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine.

PPM1D APC

1.06e-05366218371349
Pubmed

Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.

APC IL17RA

1.06e-05366225526314
Pubmed

Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart.

PRKD3 PRKD2

1.06e-05366238419169
Pubmed

SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.

SIK2 PHLPP2

1.06e-05366233128264
Pubmed

Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network.

PRKD3 PRKD2

2.12e-05466214743217
Pubmed

Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.

PPM1D APC

2.12e-05466231659152
Pubmed

Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1.

PRKD3 PRKD2

2.12e-05466227670070
Pubmed

PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.

APC PHLPP2

2.12e-05466224530606
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

FSIP2 IPO9 GPBP1 PRRC2C SIK2 APC ANKRD26 FRYL SSRP1

3.51e-0586166936931259
Pubmed

Protein kinase D regulates RhoA activity via rhotekin phosphorylation.

PRKD3 PRKD2

3.53e-05566222228765
Pubmed

SSX: a multigene family with several members transcribed in normal testis and human cancer.

SSX3 SSX5

3.53e-0556629378559
Pubmed

The armadillo repeat domain of the APC tumor suppressor protein interacts with Striatin family members.

STRN APC

3.53e-05566218502210
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

OGFRL1 NRDE2 BMP2K SETD5 FBXO7 APC FRYL ANKHD1 MGA RPS6KC1

3.59e-051084661011544199
Pubmed

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.

STRN IPO9 APC ANKHD1 MGA

5.67e-0521566535973513
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

SAMD1 CDC123 CAPN3 FBXO7 BEX4 FRYL SPARCL1

9.26e-0556066721653829
Pubmed

Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.

ANKRD26 POTEJ

1.27e-04966216364570
Pubmed

Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis.

PPM1D APC

1.27e-04966222555459
Pubmed

Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression.

SSX3 SSX5

1.27e-04966214611804
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

GPBP1 TSPYL2 APC SSRP1 THAP12 RPS6KC1

1.90e-0444066634244565
Pubmed

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

APC IL17RA

1.93e-041166223034650
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

NRDE2 LLGL2 PRRC2C SIK2 APC ANKHD1 CLSTN1

2.31e-0465066738777146
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

PRRC2C TSPYL2 SCAF11 TAF2 SSRP1 YTHDC1

2.67e-0446966627634302
Pubmed

HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.

STRN APC

2.73e-041366223277359
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

SAMD1 STRN IPO9 APC TAF2 MGA THAP12

3.29e-0468966736543142
Pubmed

Human transcription factor protein interaction networks.

ZZZ3 DNAH10 RBM33 PRRC2C SCAF11 TAF2 ANKHD1 MGA PHF10 SENP5

3.45e-041429661035140242
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

IPO9 ANKRD26 CLSTN1 YTHDC1 MGA PREX1

3.48e-0449366615368895
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

ANK1 SETD5 PRRC2C FNDC11 CLSTN1

4.27e-0433266537433992
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

STRN LLGL2 DNAH10 SETD5 ARIH2 CAPN3 APC

4.64e-0473066734857952
Pubmed

Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing.

GPBP1 TSPYL2 FBXO7 SSX2 PHLPP2 PASD1

4.76e-0452366611256614
Pubmed

The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.

BMP2K RBM33 TAF2 REV3L

5.47e-0419766420811636
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

ZZZ3 PRRC2C TAF2 SSRP1 ANKHD1 MGA

6.14e-0454966638280479
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

NRDE2 RBM33 CAPN3 BEX4 MGA

6.39e-0436366514691545
Pubmed

Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.

APC ANKRD26

6.59e-042066221689717
Pubmed

Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation.

IPO9 SCAF11

6.59e-042066212447396
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

PRKD2 ARIH2 TSPYL2 FBXO7 APC BEX4 SPARCL1 REV3L PREX1

6.95e-04128566935914814
Pubmed

DNA cloning using in vitro site-specific recombination.

GPBP1 TSPYL2 FBXO7 APC SSX2 PHLPP2 PASD1

7.62e-0479466711076863
Pubmed

CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma.

HEMGN ZNF749 SSRP1

7.73e-049466337468549
Pubmed

N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

IPO9 SETD5 CLSTN1 YTHDC1

7.85e-0421766434048709
Pubmed

PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA.

PRRC2C APC

7.99e-042266238507412
Pubmed

FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.

PRRC2C APC ANKRD26 YTHDC1

8.69e-0422366434226595
Pubmed

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

PRKD3 THAP12

9.53e-042466219706712
Pubmed

Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

PRRC2C ANKRD26 ANKHD1

1.04e-0310466310470851
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

FSIP2 SAMD1 SCAF11 TAF2 SSRP1 MGA

1.04e-0360866636089195
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

PRKD3 NRDE2 IPO9 PRRC2C SCAF11 POTEJ SSRP1 ANKHD1 PHF10

1.10e-03137166936244648
Pubmed

siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

REV3L FXYD1

1.12e-032666223435420
Pubmed

Charting the molecular links between driver and susceptibility genes in colorectal cancer.

HEMGN APC SPARCL1

1.13e-0310766324412244
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

STRN GPBP1 BMP2K APC ANKRD26 TAF2 MGA

1.16e-0385366728718761
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

SAMD1 ZZZ3 APC ANKHD1 MGA

1.20e-0341866534709266
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

SLC38A1 IPO9 TAF2 REV3L POTEJ PREX1

1.33e-0363866631182584
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

PRRC2C SCAF11 TAF2 SSRP1

1.34e-0325166431076518
Pubmed

Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

STRN POTEJ YTHDC1 APLF MMADHC

1.53e-0344266515815621
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

STRN SETD5 PCDHGA11 PRRC2C ANKRD26 POTEJ SSRP1 PREX1 RPS6KC1

1.56e-03144266935575683
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

STRN APC ANKRD26 FRYL THAP12

1.59e-0344666524255178
Pubmed

Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.

ZZZ3 TAF2 MGA

1.72e-0312466320850016
Pubmed

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

SAMD1 ZZZ3 MGA

1.76e-0312566332891193
Pubmed

The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.

BMP2K TAF2

1.80e-033366219336002
Pubmed

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.

GPBP1 FNDC11 ARIH2 CAPN3 FBXO7 HSF2 YTHDC1 SSX3 SSX5

1.83e-03147766931515488
InteractionELF4 interactions

ZZZ3 FBXO7 TAF2 MGA PHF10 SENP5

1.90e-06115656int:ELF4
InteractionPCBD2 interactions

ZZZ3 FBXO7 SSX3 SSX5

1.72e-0548654int:PCBD2
InteractionH2BC18 interactions

IPO9 DNAH10 CDC123 REV3L PHF10 THAP12

2.49e-05180656int:H2BC18
InteractionNUP43 interactions

FSIP2 ZZZ3 PRRC2C TSPYL2 APC TAF2 SSRP1 HSF2 YTHDC1 MGA

2.95e-056256510int:NUP43
GeneFamilyProtein phosphatases, Mg2+/Mn2+ dependent

PPM1D PHLPP2

5.44e-0417372701
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PRKD3 PRKD2 PREX1 PHLPP2

8.05e-04206374682
GeneFamilyAnkyrin repeat domain containing

ANK1 ANKRD26 POTEJ ANKHD1

1.46e-03242374403
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

SLC38A1 PRKD3 PRKD2 GPBP1 SETD5 RBM33 TSPYL2 SCAF11 FRYL IL17RA REV3L YTHDC1 PREX1 THAP12 TESPA1

3.41e-0614926615M40023
CoexpressionPUJANA_ATM_PCC_NETWORK

STRN ZZZ3 IPO9 CDC123 PPM1D PRRC2C ARIH2 APC ANKRD26 SCAF11 TAF2 YTHDC1 THAP12 SENP5

7.78e-0613946614M9585
ToppCellnormal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

IPO9 ANK1 DNAH10 TSPYL2 SIK2 ANKHD1 PHF10

7.37e-091746672274648b80dd74f3c948a779bba3391095964c34
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKD3 GPBP1 PRRC2C TSPYL2 HSF2 YTHDC1

4.10e-07192666aee6522d25e012231cdb905ce047295cb64d6e82
ToppCelldroplet-Marrow-nan-18m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 FBXO7 HEMGN BEX4 PHF10

8.12e-06185665a45756f91b62cf0fac3582786e5868deb8fd8435
ToppCelldroplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 FBXO7 HEMGN BEX4 PHF10

9.48e-06191665d78d4fbb0b8317dbf14e32182466a432abef3e93
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANK1 BMP2K FBXO7 HEMGN PHLPP2

9.97e-06193665305e15ee467826ee08b2617c69f250ad39c11b19
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

GPBP1 SETD5 RBM33 PRRC2C SCAF11

9.97e-06193665e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC38A1 C14orf93 GPBP1 DNAH10 PCDHGA11

9.97e-06193665088c8b1e968f5356502347eaabdc6b1b1d4befd0
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANK1 BMP2K FBXO7 HEMGN PHLPP2

9.97e-06193665dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C SCAF11 FRYL REV3L MGA

1.05e-051956657796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellLPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK1 BMP2K FBXO7 HEMGN PHLPP2

1.16e-05199665565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCellLPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK1 BMP2K FBXO7 HEMGN PHLPP2

1.16e-051996656c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCellLPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK1 BMP2K FBXO7 HEMGN PHLPP2

1.16e-05199665284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RBM33 PRRC2C SCAF11 FRYL YTHDC1

1.18e-0520066512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellwk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ANK1 HEMGN APLF SENP5

9.35e-05160664768f3cefc3ad4cda229e598cce8bde574cf64bb2
ToppCell356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells)

LLGL2 TTI1 BEX4

1.02e-0461663d0b33a48ee2faf68b270f9279c630437f3e8b20b
ToppCellControl-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.15e-04169664c2e2a7b89fe4a64d79efafdec037c4104f433061
ToppCellControl-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.15e-04169664df1fc1477bbbb285063b9b122b1ac84c87fd7fa8
ToppCellControl-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.15e-0416966492986559aa4a744e8b0487b0ae035cfb1fbf9890
ToppCellTCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9

BEST4 FXYD1 SLC30A10 PHLPP2

1.24e-0417266494842346c84542a5243bd765e49f4af8bc5182db
ToppCellTCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9

BEST4 FXYD1 SLC30A10 PHLPP2

1.24e-041726645d654dd030ed22a701e15c5f09002951d99a52e8
ToppCellLPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.32e-04175664e4c9b3c6bde390a3892b112b673f93e118220eb9
ToppCellCOVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANK1 BMP2K FBXO7 HEMGN

1.32e-041756644c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCellLPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.32e-041756644d36da7399c62c170cb603957b35a35efb2c3fbe
ToppCellLPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.32e-041756642c39c1b112e873403ad2add8595cc256bf0b97a6
ToppCellnormal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass

ANK1 DNAH10 SIK2 ANKHD1

1.35e-04176664476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCellwk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

ANK1 FBXO7 HEMGN SLC30A10

1.35e-0417666498814f0a67411b2f7b25dc489b2aadb77f45a853
ToppCellLPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.41e-04178664eafacc8cd3e986d6ca309e05b6e241331a584fa5
ToppCellLPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.41e-041786646a5c31e976852edc7d9e899da8e2a1bf23d36759
ToppCellLPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 FBXO7 HEMGN TESPA1

1.41e-04178664370749834a11d981e9ede26d5f63f0ecb551c015
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC38A1 OGFRL1 ANK1 BEX4

1.47e-041806643d54cc767e25d91ed2203d8a03e5bf5e15f21699
ToppCellHSPCs-Erythroblasts|HSPCs / Lineage and Cell class

ANK1 HEMGN BEX4 PHF10

1.50e-041816644ded490f190af7ace343acdf317edc7373484d08
ToppCellHSPCs-Erythroblasts|World / Lineage and Cell class

ANK1 HEMGN BEX4 PHF10

1.50e-04181664ce26f1accc8f69b7bc4b929073e975c887566c6a
ToppCellTCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9

BEST4 FXYD1 SLC30A10 PHLPP2

1.50e-0418166488f6f56f5f58b479d5db91b32c45934c045f88ea
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC38A1 TSPYL2 FXYD1 TESPA1

1.54e-041826649ba85f621a846531a2a7861e9df695d288c9e149
ToppCellwk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ANK1 FBXO7 HEMGN SLC30A10

1.54e-041826641adb8d6404d50155e9f9ba805abef63929fe865f
ToppCell10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CTCFL ANK1 FBXO7 HEMGN

1.60e-041846640efc757d9512d6a8fe8176e977a94e4494ed9778
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ANK1 BMP2K FBXO7 HEMGN

1.63e-04185664c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ANK1 BMP2K FBXO7 HEMGN

1.63e-04185664e8f7da9641b6cf1db1093b4f301ce828fd3a529c
ToppCell10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 FBXO7 HEMGN SLC30A10

1.63e-04185664e9059cefcdf0972ec90793b1dd34c3292b17a061
ToppCellImmune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor

ANK1 BMP2K FBXO7 HEMGN

1.67e-04186664f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3
ToppCellLPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 HEMGN TESPA1 PHLPP2

1.67e-04186664e5014443e9d6e25943308483e20d48b776ae5373
ToppCellPCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ANK1 FBXO7 HEMGN TESPA1

1.67e-041866641c39ced3b32dba2832991284720b6c5f508a2e73
ToppCellLPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 HEMGN TESPA1 PHLPP2

1.67e-04186664affc246a1091e44dc85a5e237c778a7541d5a2b4
ToppCellLPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK1 HEMGN TESPA1 PHLPP2

1.67e-0418666440d1e15402fdfb3b5ae850a2070cd4b68fda3159
ToppCellwk_08-11-Hematologic-Meg-ery-Definitive_reticulocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

ANK1 FBXO7 HEMGN TESPA1

1.67e-04186664bf8ca7135c05d772aa3f5960b419a13aef3936ae
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C SCAF11 ANKHD1 YTHDC1

1.70e-04187664663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

TTI1 BEX4 SSX5 TESPA1

1.70e-0418766455d5b21517c89736592982af40fd4cd64be62a3c
ToppCellwk_08-11-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

ANK1 FBXO7 HEMGN SLC30A10

1.70e-04187664c0965293f08d3e49000871777a5b26d81a4af203
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

OGFRL1 BMP2K IL17RA PREX1

1.74e-041886640d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC38A1 TSPYL2 FXYD1 TESPA1

1.77e-041896648130102c41b2978a8b83f765ce383f836a464795
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ANK1 BMP2K FBXO7 HEMGN

1.77e-041896641900e574870fc647bfa11c732a72f3d38aab717c
ToppCelldroplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 FBXO7 HEMGN BEX4

1.77e-0418966498ace332c3c046694c6ade47de8c8bf57ec51271
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKD3 PRRC2C TSPYL2 YTHDC1

1.85e-041916641ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC38A1 TSPYL2 HSF2 TESPA1

1.85e-04191664696921a4f160b6b55698652488ed781e855e5e51
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 HEMGN BEX4 PHF10

1.85e-0419166424ebc8d4a9fc3782510162e04fe586f7cb371eed
ToppCell10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ANK1 FBXO7 HEMGN SLC30A10

1.88e-041926646ace9a34ed264583042156ed61c2cb3504a331d2
ToppCelldroplet-Marrow-BM-1m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXO7 BEX4 SSRP1 PHF10

1.88e-04192664ced2fdbcb181ac250ff50cd4d5d886e568924203
ToppCelldroplet-Spleen-SPLEEN-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 HEMGN BEX4 PHF10

1.88e-04192664a94f47a664a3c9d1b0250269674453309ab4bf95
ToppCelldroplet-Marrow-BM-1m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXO7 BEX4 SSRP1 PHF10

1.88e-0419266419b8675ed8a99bd3d08ad043e4ec9f006426c22f
ToppCellInfluenza_Severe-RBC|Influenza_Severe / Disease group and Cell class

ANK1 FBXO7 HEMGN PHLPP2

1.88e-04192664f19b6da3fd98da1a76d2570137a8f73a3850ebcb
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TSPYL2 BEX4 FXYD1 TESPA1

1.88e-04192664348d39da3016dc6dbfa65d108e5def35aa7f19dd
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC38A1 ZNF749 SPARCL1 REV3L

1.88e-041926641d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7
ToppCellChildren_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

OGFRL1 BMP2K IL17RA PREX1

1.92e-0419366458e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

STRN SCAF11 FRYL MGA

1.92e-04193664abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ANK1 FBXO7 HEMGN SLC30A10

1.92e-041936641e19f80c52833fb21a8d597a3ba2c4ff464c4559
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC38A1 TSPYL2 FXYD1 TESPA1

1.92e-04193664c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9
ToppCellsevere_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2)

ANK1 FBXO7 HEMGN PHLPP2

1.92e-04193664ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 BMP2K FBXO7 HEMGN

1.96e-0419466423b06707d21306b4483d64cb350b86aef352ce38
ToppCellfacs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP2K PRRC2C APC SCAF11

2.00e-04195664a1478021a3ed0e779716393124ca2a7770c433b7
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C FRYL REV3L MGA

2.00e-041956643e519cffa6144a62b06124642a14c9ff39b76554
ToppCell10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 BMP2K FBXO7 HEMGN

2.04e-0419666451c48944149a89b98011a50fe81ca6664d5f0d44
ToppCell10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 BMP2K FBXO7 HEMGN

2.04e-041966642aeb792e7685e33e3543a6974be790980a41ed8c
ToppCellhematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class

ANK1 BMP2K FBXO7 TESPA1

2.08e-041976646172a1b98ff840d9174b1ab20ba0c202a7ef87af
ToppCell10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ANK1 BMP2K FBXO7 HEMGN

2.08e-04197664b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

NRDE2 PRRC2C ANKRD26 YTHDC1

2.08e-041976640fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellControl_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type

ANK1 FBXO7 HEMGN PHLPP2

2.12e-041986641a39a98beef68e1e6d3adc25270a3336fcc5baf4
ToppCellControl_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type

ANK1 FBXO7 HEMGN PHLPP2

2.12e-04198664dd80fd9671ee863aebcf4c1023d3e004cc2ee709
ToppCelldistal-Hematologic-CD4+_Naive_T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SLC38A1 TSPYL2 HEMGN TESPA1

2.12e-0419866417ea354c1feea9905adfe06a1800bd7c871b2dd7
ToppCellControl_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type

ANK1 FBXO7 HEMGN PHLPP2

2.12e-04198664cfc2a860bae883299987d3e374d0476ca20e1bdd
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PRRC2C TSPYL2 FRYL YTHDC1

2.16e-04199664f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

PRRC2C ANKRD26 SCAF11 REV3L

2.16e-04199664fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCelllymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass

SLC38A1 GPBP1 PRRC2C TSPYL2

2.16e-04199664945fbf5845403a8b22d04963f50ad69c414b6153
ToppCellPBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SLC38A1 LLGL2 TSPYL2 TESPA1

2.16e-04199664dfdf551a292e33e3ee356629fa48a0a2f009624d
ToppCellPBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SLC38A1 LLGL2 TSPYL2 TESPA1

2.16e-04199664ec7a1b0b71175b3a4015522bf88784eb176d59e3
ToppCellInfluenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class

ANK1 FBXO7 HEMGN PHLPP2

2.16e-04199664da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCellMacroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

OGFRL1 BMP2K SPARCL1 FXYD1

2.20e-04200664941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCellCOVID-19_Mild-Lymphoid_T/NK|COVID-19_Mild / Disease group, lineage and cell class

SLC38A1 LLGL2 TSPYL2 TESPA1

2.20e-04200664e69416952039ca076e9b71187d8783fe567ee873
ToppCellCOVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class

ANK1 BMP2K FBXO7 HEMGN

2.20e-04200664308f74e7e13ecc6d133c219c42cc8895a96644c8
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK|COVID-19_Mild / Disease, condition lineage and cell class

SLC38A1 LLGL2 TSPYL2 TESPA1

2.20e-042006646d9796153d038329a820949c0b88fd01265a1227
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

SAMD1 BMP2K PRRC2C YTHDC1

2.20e-042006640d76b006d8e8b32174e65e400acd0674354b962c
ToppCellmild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SLC38A1 PRRC2C TSPYL2 YTHDC1

2.20e-04200664109f673a4967ffa52270a0b4f818b3461288db44
ToppCellMacroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic

SLC38A1 OGFRL1 SPARCL1 FXYD1

2.20e-0420066488d66550781a3c9102ff7455f5cff6fb072943cd
ToppCellMacroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic

SLC38A1 OGFRL1 SPARCL1 FXYD1

2.20e-04200664d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCellMacroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic

SLC38A1 OGFRL1 SPARCL1 FXYD1

2.20e-0420066416269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCellMacroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic

SLC38A1 OGFRL1 SPARCL1 FXYD1

2.20e-04200664c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

SAMD1 BMP2K PRRC2C YTHDC1

2.20e-04200664cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCellLPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ANK1 FBXO7 HEMGN PHLPP2

2.20e-04200664fa1eaf008b54bdf7bbcdec8134460c5f64490de9
ToppCellMacroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic

SLC38A1 OGFRL1 SPARCL1 FXYD1

2.20e-0420066479634b1086934412ae92f259ab43554ce545008f
ComputationalNeighborhood of PPP5C

TTI1 FRYL TAF2 REV3L PHF10

3.64e-0591455MORF_PPP5C
ComputationalNeighborhood of PSMF1

TTI1 FRYL TAF2 REV3L MGA PHF10

6.34e-05167456MORF_PSMF1
ComputationalNeighborhood of REV3L

TTI1 FRYL TAF2 REV3L

9.64e-0558454MORF_REV3L
ComputationalNeighborhood of BRCA1

IPO9 TTI1 FRYL TAF2 REV3L MGA PHF10

9.93e-05263457MORF_BRCA1
ComputationalNeighborhood of ATRX

TTI1 FRYL TAF2 REV3L MGA PHF10

2.54e-04215456MORF_ATRX
ComputationalNeighborhood of RFC5

TTI1 FRYL TAF2 PHF10

3.05e-0478454MORF_RFC5
ComputationalNeighborhood of CCNF

TTI1 FRYL TAF2 PHF10

3.05e-0478454MORF_CCNF
ComputationalNeighborhood of RUNX1

TTI1 FRYL TAF2 MGA PHF10

4.10e-04152455MORF_RUNX1
ComputationalNeighborhood of ESR1

TTI1 FRYL TAF2 MGA PHF10

7.20e-04172455MORF_ESR1
ComputationalNeighborhood of RAB10

ZZZ3 IPO9 PRRC2C TTI1 PHF10

7.99e-04176455GCM_RAB10
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

PRKD3 C14orf93 IPO9 ARIH2 APC ANKRD26 BEX4

1.44e-061966576772_DN
DiseaseDystonia

FBXO7 SLC30A10 MMADHC

7.25e-0486603C0013421
Diseasetriglyceride measurement, very low density lipoprotein cholesterol measurement

SLC38A1 LLGL2 DNAH10 CAPN3

1.13e-03224604EFO_0004530, EFO_0008317
Diseasechylomicron measurement, very low density lipoprotein cholesterol measurement

SLC38A1 DNAH10 CAPN3

1.33e-03106603EFO_0008317, EFO_0008596
Diseasefree cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement

SLC38A1 DNAH10 CAPN3

1.48e-03110603EFO_0008317, EFO_0008591, EFO_0008596
Diseasechylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement

SLC38A1 DNAH10 CAPN3

1.48e-03110603EFO_0004574, EFO_0008317, EFO_0008596
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

SLC38A1 DNAH10 CAPN3

1.52e-03111603EFO_0004530, EFO_0008595
DiseaseParkinsonism, Juvenile

FBXO7 SLC30A10

1.71e-0330602C0752105
Diseasered blood cell density measurement

PRKD3 ANK1 DNAH10 BMP2K FBXO7 HSF2 PREX1

2.00e-03880607EFO_0007978
Diseasecoronary artery disease

SLC38A1 PRKD2 DNAH10 CDC123 HEMGN SIK2 SCAF11 PREX1

2.78e-031194608EFO_0001645
Diseasetriglyceride measurement, phospholipid measurement

SLC38A1 DNAH10 CAPN3

3.30e-03146603EFO_0004530, EFO_0004639
Diseasealcohol consumption measurement

SLC38A1 ZZZ3 IPO9 ARIH2 SCAF11 MGA SLC30A10 PHLPP2

3.53e-031242608EFO_0007878
Diseasecandidiasis (implicated_via_orthology)

PRKD3 PRKD2

3.64e-0344602DOID:1508 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
NPFGEDDDDFETNQL

BEST4

311

Q8NFU0
EDNDNVGQPNEYDLN

APLF

451

Q8IW19
NSNVEEQEDQPTAGQ

CTCFL

221

Q8NI51
NEGGEQAPTQNEEES

BEX4

21

Q9NWD9
PGEQVTEEQFTDEQG

ANK1

1806

P16157
NSQGSDSNEEDYDPN

ARIH2

6

O95376
QEFSGVENDNETEPV

CLSTN1

506

O94985
ESSEEEEGEQGDPQN

CLSTN1

951

O94985
EEEQEREGSENNQPQ

ANKRD26

531

Q9UPS8
QGEQGDFNDDDTEPE

BMP2K

766

Q9NSY1
NTNDQSGEQESEYEQ

RBM33

106

Q96EV2
DINDNAPSFQEDEVE

PCDHGA11

126

Q9Y5H2
NEFQGNDAPVEQEIN

MMADHC

121

Q9H3L0
PYEEEQRQSVQSDQG

IL17RA

781

Q96F46
VSPENNEEGGNDNQD

OGFRL1

421

Q5TC84
TDTDPNENFSAQGED

LLGL2

471

Q6P1M3
QQKGFDNPEENSSEF

MGA

2116

Q8IWI9
QDDSNQEDDGQDSSP

RPS6KC1

481

Q96S38
NFDENEIPQENGNAS

GPBP1

346

Q86WP2
NAISNSEFQPQVEEE

FSIP2

6291

Q5CZC0
SQDEEEQDGFPEVQT

FRYL

2646

O94915
ESEEPNQGNNAAADT

NRDE2

131

Q9H7Z3
QQQRTGEPDEEEGTF

FXYD1

66

O00168
SGTFPFNEDEDINDQ

PRKD2

746

Q9BZL6
SGTFPFNEDEDINDQ

PRKD3

771

O94806
SPEVDNQGNFTNEDE

PPM1D

376

O15297
QNPAEPEEYNETDQG

HEMGN

276

Q9BXL5
ETNNSNAQNPSEEEG

THAP12

131

O43422
NAQNPSEEEGEGQDE

THAP12

136

O43422
QDENCGQQEDESQSF

PASD1

626

Q8IV76
QSPKDDNEDNSNDGT

PHF10

26

Q8WUB8
NGDFSEVDAQEQDSP

CDC123

271

O75794
QDEQPSDSFQGQAAQ

FBXO7

116

Q9Y3I1
GPSQNFEAESIQDNA

FBXO7

141

Q9Y3I1
GNPQSFLDQEEADDQ

FNDC11

16

Q9BVV2
NFQEEEDEGGDENAP

C14orf93

496

Q9H972
NPQQFVEDEDDDTFS

IPO9

381

Q96P70
QGEQGDFNDNDTEPE

BMP2KL

21

Q5H9B9
PGSSDQESEEQQQFR

CAPN3

641

P20807
DNFGQLPDDVENNQT

DNAH10

3786

Q8IVF4
FPEQATAFQEQEIDG

SAMD1

476

Q6SPF0
TFGNEDFNNIQDSEN

SCAF11

651

Q99590
TQNTQYNDAEDEGGP

MUCL3

481

Q3MIW9
NEDEYAPVIQSGEQN

HSF2

291

Q03933
DSDEGNETEVQPQQN

STRN

136

O43815
VGFQNPFSSSQDEEE

TAF2

1031

Q6P1X5
QLNFSDDDEQGSNSP

PRRC2C

331

Q9Y520
DDDEQGSNSPKENNS

PRRC2C

336

Q9Y520
RTPENQQFPDNESEE

POTEJ

416

P0CG39
TEDPSGEQAQEEDQA

PREX1

806

Q8TCU6
GEQAQEEDQADSAFP

PREX1

811

Q8TCU6
VTDFQGNDFDNDPNR

SSX3

76

Q99909
EASEENNDQQSQEVP

SETD5

456

Q9C0A6
EQENEPSIGEFNEQV

SIK2

286

Q9H0K1
QEDGVDPVEAFAQNV

SSRP1

171

Q08945
DNDVDDEQQSPPSAE

ANKHD1

906

Q8IWZ3
PPVQENDNGNETESE

APC

1526

P25054
NVAGDSFNTQNEPED

SLC30A10

211

Q6XR72
DEAFPDQQNGSATNA

SENP5

341

Q96HI0
RDTQDGEAFQGEQND

ZNF749

181

O43361
EVPNNETTDNNESAD

TSPYL2

486

Q9H2G4
DDNEENPNNNENTYG

TSPYL2

526

Q9H2G4
NQSDNGLDSDDDQPV

PHLPP2

1141

Q6ZVD8
GNNKYPQNSDDEENE

REV3L

441

O60673
GTADENSDNPLNNEN

REV3L

526

O60673
AEDFQGNDLDNDPNR

SSX2

76

Q16385
VADFQGNDFDNDPNR

SSX5

76

O60225
QEQDPNISNGEEEEE

SPARCL1

191

Q14515
FDQGNQEQEDNSNAE

SPARCL1

261

Q14515
SDEQGNNTENEEEGV

YTHDC1

191

Q96MU7
QQDSDLGQFSQEDPV

TESPA1

331

A2RU30
ENGQFEENNLSPNET

ZZZ3

401

Q8IYH5
NDSNDFTEVENGQIN

SLC38A1

26

Q9H2H9
NVSDFDNEEEEQSVP

TTI1

826

O43156